A choice that matters?: Simulation study on the impact of direct meta-analysis methods on health economic outcomes

PharmacoEconomics

Volumn 31, Issue 8, 2013, Pages 719-730

  Vemer, Pepijn ^a   Al, Maiwenn J ^a   Oppe, Mark ^a   Rutten Van Mölken, Maureen P M H ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BAYESIAN FIXED EFFECT; BAYESIAN LEARNING; BAYESIAN RANDOM EFFECT; CLINICAL TRIAL (TOPIC); CONFIDENCE INTERVAL; COST EFFECTIVENESS ANALYSIS; FEMALE; FREQUENTIST FIXED EFFECT; FREQUENTIST RANDOM EFFECT; HEALTH ECONOMICS; HUMAN; MACHINE LEARNING; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); MODEL; OUTCOME ASSESSMENT; PARAMETERS; PRIORITY JOURNAL; PROBABILITY; SENSITIVITY ANALYSIS; SIMULATION; STATISTICS; ADOLESCENT; BAYES THEOREM; COST BENEFIT ANALYSIS; MIDDLE AGED; STATISTICAL BIAS; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGED; BAYES THEOREM; BIAS (EPIDEMIOLOGY); COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; MARKOV CHAINS; META-ANALYSIS AS TOPIC; MIDDLE AGED; MODELS, ECONOMIC;

EID: 84881189038     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.1007/s40273-013-0067-0     Document Type: Article

References (21)

1. NZa. Beleidsregel Dure Geneesmiddelen [Policy rule Expensive Drugs] (BR-CU-2017). 2011. http://www.nza.nl/regelgeving/beleidsregels/ziekenhuiszorg/ BR-CU-2017. Accessed 15 June 2011.
2. Cooper NJ, Sutton AJ, Abrams KR, Turner D, Wailoo A. Comprehensive decision analytical modelling in economic evaluation: a Bayesian approach. Health Econ. 2004;13(3):203-26.
3. Ades AE, Sculpher M, Sutton A, Abrams K, Cooper N, Welton N, et al. Bayesian methods for evidence synthesis in cost-effectiveness analysis. Pharmacoeconomics. 2006;24(1):1-19.
4. Riley RD, Simmonds MC, Look MP. Evidence synthesis combining individual patient data and aggregate data: a systematic review identified current practice and possible methods. J Clin Epidemiol. 2007;60(5):431-9.
5. Brockwell SE, Gordon IR. A comparison of statistical methods for meta-analysis. Stat Med. 2001;20(6):825-40.
6. Sutton AJ, Abrams KR. Bayesian methods in meta-analysis and evidence synthesis. 2001;10(4):277-303.
7. Sutton AJ, Higgins JP. Recent developments in meta-analysis. Stat Med. 2008;27(5):625-50.
8. Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions 5.0.2, updated September 2009. Available at http://www.cochrane-handbook.org/.
9. Oppe M, Al M, Rutten-van Molken M. Comparing methods of data synthesis: re-estimating parameters of an existing probabilistic cost-effectiveness model. Pharmacoeconomics. 2011;29(3):239-50.
10. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-60.
11. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-88.
12. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-58.
13. Gelman A, Carlin JB, Stern HS, Rubin DB. Bayesian data analysis. London: Chapman & Hall; 1995.
14. Carlin BP, Louis TA. Bayes and empirical Bayes methods for data analysis. London: Chapman & Hall; 1996.
15. Jaynes E. Confidence intervals vs Bayesian intervals. In: Harper W, Hooker CA, editors. Foundations of probability theory, statistical inference, and statistical theories of science. Dordrecht: D Reidel; 1976. p. 175.
16. O'Hagan A, Luce B. A primer on Bayesian statistics in health economics and outcomes research. Sheffield: Centre for Bayesian Statistics in Health Economics; 2003.
17. Lambert PC, Sutton AJ, Burton PR, Abrams KR, Jones DR. How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS. Stat Med. 2005;24(15):2401-28.
18. Song F, Altman DG, Glenny AM, Deeks JJ. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ. 2003;326(7387):472.
19. Strassmann R, Bausch B, Spaar A, Kleijnen J, Braendli O, Puhan MA. Smoking cessation interventions in COPD: a network meta-analysis of randomised trials. Eur Respir J. 2009;34(3):634-40.
20. Puhan MA, Bachmann LM, Kleijnen J, Ter Riet G, Kessels AG. Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis. BMC Med. 2009;14(7):2.
21. Lu G, Ades AE. Assessing evidence inconsistency in mixed treatment comparisons. J Am Stat Assoc. 2006;101:447-59.